Republished: Which antibody and which cancer in which paraneoplastic syndromes?

9Citations
Citations of this article
63Readers
Mendeley users who have this article in their library.

Abstract

Paraneoplastic neurological syndromes can be associated with the presence of onconeural antibodies. These antibodies are the result of an immune response against a tumour that is ectopically expressing a neuronal antigen. The 'classical' onconeural antibodies (anti-Hu, Yo, Ma2, CRMP-5, amphiphysin and Ri) are directed against intracellular antigens and are strongly associated with underlying malignancy. By contrast, onconeural antibodies directed against cell surface antigens (eg, anti-NMDA, VGKC, AChR) have a weaker tumour association. This article gives a practical overview of the tumour associations, and the neurological associations, of the onconeural antibodies. There is also guidance on how to investigate occult malignancy in antibody positive cases.

Cite

CITATION STYLE

APA

Gozzard, P., & Maddison, P. (2011, January). Republished: Which antibody and which cancer in which paraneoplastic syndromes? Postgraduate Medical Journal. https://doi.org/10.1136/jnnp.2010.224105rep

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free